Cambridge, United Kingdom

Miha Kosmac

USPTO Granted Patents = 21 

 

Average Co-Inventor Count = 5.7

ph-index = 9

Forward Citations = 261(Granted Patents)


Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
21 patents (USPTO):

Title: The Innovations of Miha Kosmac in the Field of Anti-PD-L1 Antibodies

Introduction

Miha Kosmac is an accomplished inventor located in Cambridge, GB, known for his significant contributions to the field of biotechnology, particularly in the development of anti-PD-L1 antibodies. With an impressive portfolio of 20 patents, Kosmac has been at the forefront of innovative treatments that aim to enhance cancer therapies.

Latest Patents

Among his latest patents, Kosmac focuses on the development of anti-PD-L1 antibodies. These patents detail bispecific antibodies that contain one domain specifically targeting PD-L1, as well as immunocytokines that fuse an anti-PD-L1 antibody with a cytokine, such as IL-2. The inventions encompass methods of treatment and pharmaceutical compositions that utilize these antibodies and related constructs, paving the way for advancements in cancer therapy.

Career Highlights

Miha Kosmac’s career has been marked by relentless innovation at Kymab Limited, where he applies his expertise to the development of groundbreaking therapies. His work significantly contributes to the understanding and treatment of various cancers, positioning him as a leading figure in the biopharmaceutical field.

Collaborations

Throughout his career, Kosmac has collaborated with various notable professionals, including Ian Kirby and Jamie Iain Campbell. These partnerships foster a creative and productive environment, driving forward-thinking research and development initiatives within Kymab Limited.

Conclusion

Miha Kosmac stands out as a prominent inventor in the realm of biopharmaceutical innovations. His focus on creating effective treatments through anti-PD-L1 antibodies exemplifies the vital intersection of science and innovation, ultimately benefiting patients facing the challenges of cancer. With a robust portfolio of patents and a dedication to advancing healthcare, Kosmac's contributions are set to have a lasting impact on the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…